Related Experiment Videos

Treatment of chronic hypertension for the prevention of stroke

Andrew M Naidech1, Leon A Weisberg

  • 1Department of Internal Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA.

Southern Medical Journal
|August 15, 2003
PubMed

Insights

Effective hypertension management is crucial for stroke prevention. This review highlights recent trials and guidelines for treating high blood pressure to reduce stroke risk.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Limited effective therapies for acute stroke necessitate a focus on prevention.
  • Chronic hypertension is a significant modifiable risk factor for stroke.
  • Current treatment strategies require nuanced, evidence-based approaches.

Purpose of the Study:

  • To review recent randomized trials on hypertension management.
  • To provide evidence-based guidelines for hypertension treatment.
  • To emphasize primary and secondary stroke prevention through blood pressure control.

Main Methods:

  • Review of major recent randomized clinical trials.
  • Synthesis of evidence for hypertension treatment efficacy.
  • Development of practical guidelines for clinical application.

Main Results:

  • Certain antihypertensive agents show particular benefit in recent trials.
  • No single treatment approach is universally optimal for all patients.
  • Evidence supports tailored hypertension management for stroke prevention.

Conclusions:

  • Optimizing chronic hypertension treatment is key to reducing stroke incidence.
  • Recent trial data inform more effective, individualized therapeutic strategies.
  • Implementing evidence-based guidelines can improve primary and secondary stroke prevention outcomes.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...